Join to access to all OVN content. Join for Free

Results for 'clinical'

The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)
Partner Avatar MSL Talk: Tom Caravela, Jessica Johnson, Whitney Theiss
The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)

Clinical Practice Liaison, Field Medical Positions, Medical Science Liaisons, Transition to Industry, Emotional Intelligence in Healthcare

In this episode, Jessica Johnson and Whitney Theiss from Neurocrine Biosciences join Tom Caravela to explore the transition from clinical roles to field medical positions, focusing on the Clinical Practice Liaison (CPL) role. They discuss the responsibilities and skills required for CPLs, compa…

Mar 30th • 35 mins listen

How and Why Medical Affairs Can Support Diversity in Clinical Trials
Partner Avatar MSL Talk: Tom Caravela, Brad Atkinson, Brian Wilson, Christina Wright
How and Why Medical Affairs Can Support Diversity in Clinical Trials

diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship

In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …

Aug 24th • 42 mins listen

Engagement Strategies: Crafting Your Story to Clinical Professionals
Partner Avatar MSL Talk: Tom Caravela, Ryan Norman
Engagement Strategies: Crafting Your Story to Clinical Professionals

pharmaceutical industry, clinical expertise, business insights, MSL role, virtual engagements

In this episode, Ryan Norman joins Tom Caravela to discuss his journey into the pharmaceutical industry and how he successfully blended clinical expertise with business insights in his role as an MSL. Ryan delves into effective strategies for preparing for KOL meetings, aligning messaging with …

Sep 14th • 31 mins listen

The Misalignment of Clinical Development and Field Medical Affairs
Partner Avatar MSL Talk: Tom Caravela, Carrie Caretta, Giancarlo Maranzano
The Misalignment of Clinical Development and Field Medical Affairs

clinical development, field medical affairs, MSLs recruitment, pharmaceutical strategies, Boehringer Ingelheim

In this episode, Tom Caravela is joined by Carrie Caretta and Giancarlo Maranzano from Boehringer Ingelheim to explore the integration of clinical development and field medical affairs. They discuss the strategic role of field medical teams in clinical trial recruitment and how MSLs can effecti…

Mar 22nd • 29 mins listen

Evolving Role of MSL Field Support for Clinical Trials
Partner Avatar MSL Talk: Tom Caravela, Khalil Ahmed
Evolving Role of MSL Field Support for Clinical Trials

Medical Science Liaisons, clinical trials, MSL involvement, Syneos Health, Khalil Ahmed

In this episode, Tom Caravela is joined by Khalil Ahmed to explore the integral role of Medical Science Liaisons (MSLs) in clinical trials. Khalil shares his background and discusses the significant impact MSLs have on site selection, recruitment, and training. The conversation delves into the …

Apr 4th • 34 mins listen

The Evolving Role of Clinical Educators for Pharma and Field Medical
Partner Avatar MSL Talk: Tom Caravela, Michelle Offner
The Evolving Role of Clinical Educators for Pharma and Field Medical

clinical educator, medical field, clinical education, networking, health outcomes

In this episode, Michelle Offner shares her journey from her previous roles to becoming a clinical educator. She delves into the responsibilities and importance of clinical educators, highlighting the skills and value they bring to the medical field. Michelle discusses the challenges faced in this r…

Sep 17th • 26 mins listen

Is it Ever Too Early or Too Late
Partner Avatar MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late

Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization

In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…

Feb 18th • 34 mins listen

From Clinical to Medical Device MSL and Beyond
Partner Avatar MSL Talk: Tom Caravela, Maria Abunto
From Clinical to Medical Device MSL and Beyond

Medical Science Liaison, MSL roles, medical device industry, transitioning MSL, International MSL Day

In this episode, Maria Abunto joins Tom Caravela to discuss her journey from clinical practice to becoming a successful Medical Science Liaison (MSL) in the medical device industry. Maria shares insights on why clinicians are well-suited for MSL roles and the importance of mentors and career co…

Apr 20th • 28 mins listen

IO Clinical Trials During COVID-19
OVN Avatar Cancer Buzz Podcast
IO Clinical Trials During COVID-19

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …

Jun 23rd • 13 mins listen

Improving Community Clinical Trial Participation
OVN Avatar Cancer Buzz Podcast
Improving Community Clinical Trial Participation

Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioriti…

Oct 13th • 6 mins listen

Increasing Clinical Trial Access for Blood Cancers
OVN Avatar Cancer Buzz Podcast
Increasing Clinical Trial Access for Blood Cancers

Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…

Jun 7th • 19 mins listen

The Role of the Clinical Trials Navigator
OVN Avatar Cancer Buzz Podcast
The Role of the Clinical Trials Navigator

Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment crit…

Aug 29th • 6 mins listen

Clinical Trial Access in Rural Areas
OVN Avatar Cancer Buzz Podcast
Clinical Trial Access in Rural Areas

Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …

Oct 16th • 24 mins listen

Advancing Clinical Trial Equity
OVN Avatar Cancer Buzz Podcast
Advancing Clinical Trial Equity

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…

Jun 25th • 8 mins listen

The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies

This podcast discusses whether the primary outcomes and study design for the reported trial were properly pre-specified and pre-registered prior to accruing participants.

Jan 24th • 12 mins listen

How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
OVN Avatar ournal of Clinical Oncology (JCO) Podcast
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?

This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and the complexity of modernizing eligibility while maintaining trial integrity.

Mar 25th • 10 mins listen

 ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?

Current clinical characteristics and demographics are not sufficient to capture aggressive disease in clinical trials of newly diagnosed DLBCL. Novel tools, such as measurement of tumor burden via ctDNA, are needed. By : Dr. Matthew Maurer.

Apr 10th • 7 mins listen

 Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership

Shannon Westin, Pamela Kunz, and Rachna Shroff discuss the lack of gender equity on oncology industry advisory boards.

Nov 25th • 23 mins listen

Improving Transparency in Phase 1 Clinical Trials
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
Improving Transparency in Phase 1 Clinical Trials

Dr. Shannon Westin and her guests, Dr. Paul Frankel, Dr. Judith Karp, and Dr. Robert Maki discuss how to better inform patients of the risks involved in phase 1 clinical trials.

Feb 9th • 29 mins listen

Barriers to Clinical Trial Participation for Transgender People
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
Barriers to Clinical Trial Participation for Transgender People

What factors could be excluding transgender people from oncology clinical trials, and what can we do to make them more inclusive? Dr. Westin discusses this important issue with her guests, Dr. Ash Alpert and Dr. Lola Fashoyin-Aje.

Apr 25th • 26 mins listen

Related Topics

Loading...